Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness

NCT00385385 is registered in ClinicalTrials.gov with ActivBiotics as lead sponsor.

NCT NCT00385385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00385385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Lead sponsor
ActivBiotics
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2006
Completion date
September 30, 2008
Enrollment
72 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular disease, coronary artery disease, peripheral vascular disease